Our study elucidated that withaferin A suppresses HCC proliferation, migration, and invasion via the activation of LXR-α and negatively regulates NF-ҡB target genes (Shiragannavar et al., 2021; Shiragannavar et al., 2022). This evidence concerns the gene NR1H3 and hepatocellular carcinoma.